Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-16.98M |
|
-- |
|
-- |
|
$19.77M |
|
$-19.77M |
|
$2.80M |
|
$-16.98M |
|
$-16.98M |
|
$-16.98M |
|
$-16.98M |
|
$-16.98M |
|
$-16.98M |
|
$-19.77M |
|
$-19.90M |
|
12.20M |
|
12.20M |
|
$-1.39 |
|
$-1.39 |
|
| Balance Sheet Financials | |
$137.36M |
|
$0.30M |
|
$2.57M |
|
$139.93M |
|
$11.62M |
|
-- |
|
$1.21M |
|
$12.82M |
|
$127.11M |
|
$127.11M |
|
$127.11M |
|
12.23M |
|
| Cash Flow Statement Financials | |
$-16.42M |
|
$18.12M |
|
-- |
|
$17.87M |
|
$19.57M |
|
$1.70M |
|
$1.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.82 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.36% |
|
-13.36% |
|
-12.13% |
|
-13.36% |
|
$10.39 |
|
$-1.35 |
|
$-1.35 |
|